Agilis Biotherapeutics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$534M
Agilis Biotherapeutics General Information
Description
Developer of DNA based therapeutics designed to treat life-threatening or fatal rare diseases. The company's DNA based therapeutics uses the transformative approach based on delivering a corrected copy of a naturally occurring gene directly to targeted cells designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central nervous system.
Contact Information
Website
www.agilisbio.comCorporate Office
- Kendall Square, 245 First Street
- Suite 1800
- Cambridge, MA 02142
- United States
Corporate Office
- Kendall Square, 245 First Street
- Suite 1800
- Cambridge, MA 02142
- United States
Agilis Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 23-Aug-2018 | $534M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | 24-Feb-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 25-Jan-2016 | $5M | Cancelled | Startup | ||
| 1. Early Stage VC (Series A) | 24-Dec-2013 | $8M | $8M | Completed | Startup |
Agilis Biotherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Agilis Biotherapeutics Comparisons
Industry
Financing
Details
Agilis Biotherapeutics Competitors (53)
One of Agilis Biotherapeutics’s 53 competitors is Genetix Biotherapeutics, a Private Equity-Backed company based in Somerville, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| Adverum Biotechnologies | Formerly VC-backed | Redwood City, CA | ||||
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Prevail Therapeutics | Formerly VC-backed | New York, NY | ||||
| ERS Genomics | Corporate Backed or Acquired | Dublin, Ireland |
Agilis Biotherapeutics Patents
Agilis Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11998618-B2 | Frataxin expression constructs | Active | 09-Nov-2016 | ||
| US-20210177991-A1 | Frataxin expression constructs | Active | 09-Nov-2016 | ||
| US-20240000973-A1 | Frataxin expression constructs | Inactive | 09-Nov-2016 | A61K48/0058 |
Agilis Biotherapeutics Signals
Agilis Biotherapeutics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioMatrix Partners | Venture Capital | Minority | ||
| Gold Bench Capital | Venture Capital | Minority | ||
| Sands Capital | Growth/Expansion | Minority | ||
| Third Security | Venture Capital | Minority | ||
| WhiteRock Capital Partners | Investment Bank | Minority |
Agilis Biotherapeutics Investments (1)
Agilis Biotherapeutics’s most recent deal was a Joint Venture with Adeno-Associated Virus Gene Therapies (Agilis Biotherapeutics & Gene Therapy Research Institution). The deal was made on 02-Aug-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Adeno-Associated Virus Gene Therapies (Agilis Biotherapeutics & Gene Therapy Research Institution) | 02-Aug-2017 | Joint Venture | Drug Discovery |
Agilis Biotherapeutics FAQs
-
When was Agilis Biotherapeutics founded?
Agilis Biotherapeutics was founded in 2013.
-
Where is Agilis Biotherapeutics headquartered?
Agilis Biotherapeutics is headquartered in Cambridge, MA.
-
What is the size of Agilis Biotherapeutics?
Agilis Biotherapeutics has 8 total employees.
-
What industry is Agilis Biotherapeutics in?
Agilis Biotherapeutics’s primary industry is Biotechnology.
-
Is Agilis Biotherapeutics a private or public company?
Agilis Biotherapeutics is a Private company.
-
What is the current valuation of Agilis Biotherapeutics?
The current valuation of Agilis Biotherapeutics is .
-
What is Agilis Biotherapeutics’s current revenue?
The current revenue for Agilis Biotherapeutics is .
-
How much funding has Agilis Biotherapeutics raised over time?
Agilis Biotherapeutics has raised $20.7M.
-
Who are Agilis Biotherapeutics’s investors?
BioMatrix Partners, Gold Bench Capital, Sands Capital, Third Security, and WhiteRock Capital Partners have invested in Agilis Biotherapeutics.
-
Who are Agilis Biotherapeutics’s competitors?
Genetix Biotherapeutics, Adverum Biotechnologies, Regenxbio, Prevail Therapeutics, and ERS Genomics are some of the 53 competitors of Agilis Biotherapeutics.
-
When was Agilis Biotherapeutics acquired?
Agilis Biotherapeutics was acquired on 23-Aug-2018.
-
Who acquired Agilis Biotherapeutics?
Agilis Biotherapeutics was acquired by PTC Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process